• Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer.

    Cecil, D.L., Curtis, B., Gad, E., Gormley, M., Timms, A.E., Corulli, L., Bos, R., Damle, R.N., Sepulveda, M.A. and Disis, M.L. Scientific Reports 12, no. 1 (2022): 13618.

    1. Cancer Vaccine Institute, University of Washington, 850 Republican Street, Brotman Bld., 2nd Floor, Box 358050, Seattle, WA 98195-8050, USA.
    2. Janssen Research and Development LLC, Spring House, PA, USA.
    3. Janssen Vaccines and Prevention, Leiden, The Netherlands.

    The peptides were constructed and purified by high-performance liquid chromatography (> 90% pure; CPC Scientific).

    Published On: August 10th, 2022Categories: Citations
  • Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer’s disease.

    Libiger, O., Shaw, L.M., Watson, M.H., Nairn, A.C., Umaña, K.L., Biarnes, M.C., Canet‐Avilés, R.M., Jack Jr, C.R., Breton, Y.A., Cortes, L. and Chelsky, D. Alzheimer's & Dementia 17, no. 12 (2021): 1976-1987.

    1. Janssen Research and Development, 3210 Merryfield Row, San Diego, CA 92121, USA.
    2. Foundation for the National Institutes of Health, North Bethesda, Maryland, USA
    3. Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
    4. Merck & Co., Inc., West Point, Pennsylvania, USA

    Purified synthetic stable isotope (15N and 13C) labeled (SIL) peptides were from CPC Scientific (EDSLEAGLPLQVR [CMGA]; SLGVGFATR [FABPH]; VLEYLNQEK [SCG2]; and THLGEALAPLSK [VGF]); and JPT Peptide Technologies (TNYLYGK [NPTX2]).

    Published On: March 13th, 2021Categories: Citations, Isotope-Labeled Peptides